Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
Long-term Ten Years Follow-up in Patients Affected With Acrofacial Vitiligo
Long-term Ten Years Follow-up in Patients Affected With Acrofacial Vitiligo
Sponsor study identifier
observational
100
1 country
1
Study Start
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Acrofacial vitiligo is a clinical form of vitiligo characterized by macules in distal digits, periorificial-facial and ano-genital areas. Vitiligo European Task Force classifies vitiligo as generalized or localized; generalized vitiligo may be further sub-divided into acrofacial, vulgaris and universalis, and localized vitiligo, into segmental and focal. Some authors do not believe that acrofacial is a real vitiligo clinical form, considering it as an initial form of vulgaris vitiligo. The aim of this study is to follow early- diagnosed acrofacial patients during ten years in order to define if these patients will maintain this clinical form or will evolute to a more severe clinical form.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 21, 2011
Actual (reported)October 25, 2011
Actual (reported)May 2016
Date type not reportedThis date has not been verified as actual or estimated.
January 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Patients of both genders affected by acrofacial vitiligo diagnosed by one single dermatologist.
Irmandade da Santa Casa de Misericórdia de Curitiba
Curitiba, Paraná, 80730000, Brazil
Caio C Silva de Castro, MD, PhD
Irmandade da Santa Casa de Misericórdia de Curitiba
First Submitted
October 21, 2011
First Posted
October 25, 2011
Study Start
May 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2017
Estimated (date passed)Efficacy and Safety of ACH24 in the Treatment of Vitiligo
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 3, 2016
Record last verified: 2016-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: